(IBTI) iShares iBonds Dec 2028 - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E8333

Treasury,Bond,Fixed,Income,Maturity

Description: IBTI iShares iBonds Dec 2028 August 23, 2025

The iShares iBonds Dec2028 Term Treasury ETF (IBTI) is a target maturity ETF that tracks a specific segment of the US Treasury market, providing investors with a defined maturity schedule and a predictable income stream. As a Treasury ETF, its performance is closely tied to interest rates and the overall shape of the yield curve.

Key drivers of the funds performance include changes in US monetary policy, inflation expectations, and the overall demand for US Treasuries. The funds maturity profile, set to mature in December 2028, makes it sensitive to shifts in the yield curve, particularly in the 10-year to 15-year segment. As a result, investors should monitor the Federal Reserves actions, economic indicators such as GDP growth and inflation rates, and global events that impact US Treasury demand.

To evaluate the funds performance, investors can track key metrics such as yield to maturity, duration, and the funds tracking error relative to its benchmark. The funds yield to maturity is a critical KPI, as it reflects the total return an investor can expect if they hold the fund until maturity. Additionally, the funds duration, which measures its sensitivity to interest rate changes, is essential in assessing potential price volatility.

The funds assets under management (AUM) of $1.082 billion indicate a moderate level of investor interest. As a relatively liquid ETF, with an average trading volume of 155,300 shares, investors can enter or exit positions with relative ease. However, investors should remain aware of potential liquidity risks, particularly during periods of market stress.

To make informed investment decisions, investors should consider the funds characteristics, such as its maturity profile, yield, and duration, in the context of their overall investment objectives and risk tolerance. By doing so, they can effectively utilize IBTI as a component of a broader investment strategy, potentially benefiting from the funds predictable income stream and relatively low credit risk.

IBTI ETF Overview

Market Cap in USD 1,209m
Category Target Maturity
TER 0.07%
IPO / Inception 2020-02-25

IBTI ETF Ratings

Growth Rating 54.8%
Fundamental -
Dividend Rating 76.3%
Return 12m vs S&P 500 -7.24%
Analyst Rating -

IBTI Dividends

Dividend Yield 12m 3.55%
Yield on Cost 5y 3.46%
Annual Growth 5y 55.74%
Payout Consistency 100.0%
Payout Ratio %

IBTI Growth Ratios

Growth Correlation 3m 89.2%
Growth Correlation 12m 98.1%
Growth Correlation 5y -24.8%
CAGR 5y 4.37%
CAGR/Max DD 3y (Calmar Ratio) 0.81
CAGR/Mean DD 3y (Pain Ratio) 3.18
Sharpe Ratio 12m 0.58
Alpha -7.65
Beta 0.680
Volatility 1.88%
Current Volume 316.5k
Average Volume 20d 198.2k
Stop Loss 21.6 (-3.4%)
Signal 0.65

What is the price of IBTI shares?

As of November 09, 2025, the stock is trading at USD 22.37 with a total of 316,478 shares traded.
Over the past week, the price has changed by +0.16%, over one month by +0.39%, over three months by +1.27% and over the past year by +5.77%.

Is iShares iBonds Dec 2028 a good stock to buy?

Partly, yes. Based on ValueRay´s Analyses, iShares iBonds Dec 2028 (NASDAQ:IBTI) is currently (November 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 54.78 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBTI is around 21.22 USD . This means that IBTI is currently overvalued and has a potential downside of -5.14%.

Is IBTI a buy, sell or hold?

iShares iBonds Dec 2028 has no consensus analysts rating.

What are the forecasts/targets for the IBTI price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 23.7 5.8%

IBTI Fundamental Data Overview November 04, 2025

Market Cap USD = 1.21b (1.21b USD * 1.0 USD.USD)
Beta = 0.68
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.21b USD (1.21b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.21b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.21b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.52% (E(1.21b)/V(1.21b) * Re(8.52%) + (debt-free company))
Discount Rate = 8.52% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for IBTI ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle